Details for 2014751357

Up to date per 03.04.2026

Actions

Title / Product Name

MODULATION DER APOLIPOPROTEIN-C-III (AOPCIII)-EXPRESSION IN LIPOPROTEINLIPASEDEFIZIENTEN (LPLD) POPULATIONEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2014751357

EP Publication Number

2956176

E-Number

1011703

Language

PCT Number

US14016546

Publication Date

23.12.2015 A

27.06.2018 B1

Registration Date

27.06.2018

AT Publication Date

15.07.2018

Application Date

14.02.2014

Registration Number

Priorities

14.02.2013

201361764969 P

20.09.2013

201361880779 P

IPC

A61K 31/7088 20060101AFI20170530BHEP

Maximum Duration of Protection

14.02.2034

Owner

Ionis Pharmaceuticals, Inc.2855 Gazelle Court Carlsbad, CA 92010US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

ALEXANDER, Veronica, J.2855 Gazelle Court Carlsbad, CA 92010US

VINEY, Nicholas, J.2855 Gazelle Court Carlsbad, CA 92010US

WITZTUM, Joseph, L.6912 Ofria Court San Diego, CA 92120US

Information about Fees